Recently, the role of kidney pericytes in kidney
fibrosis has been investigated. This study aims to evaluate the effect of
paricalcitol on
hypoxia-induced and TGF-β1-induced injury in kidney pericytes. The primary cultured pericytes were pretreated with
paricalcitol (20 ng/mL) for 90 min before inducing injury, and then they were exposed to TGF-β1 (5 ng/mL) or
hypoxia (1% O2 and 5% CO2). TGF-β1 increased α-SMA and other
fibrosis markers but reduced PDGFRβ expression in pericytes, whereas
paricalcitol reversed the changes.
Paricalcitol inhibited the TGF-β1-induced cell migration of pericytes.
Hypoxia increased TGF-β1, α-SMA and other
fibrosis markers but reduced PDGFRβ expression in pericyte, whereas
paricalcitol reversed them.
Hypoxia activated the HIF-1α and downstream molecules including
prolyl hydroxylase 3 and
glucose transporter-1, whereas
paricalcitol attenuated the activation of the HIF-1α-dependent molecules and TGF-β1/Smad signaling pathways in hypoxic pericytes. The gene silencing of HIF-1α vanished the
hypoxia-induced TGF-β1, α-SMA upregulation, and PDGFRβ downregulation. The effect of
paricalcitol on the HIF-1α-dependent changes of
fibrosis markers was not significant after the gene silencing of HIF-1α. In addition,
hypoxia aggravated the oxidative stress in pericytes, whereas
paricalcitol reversed the oxidative stress by increasing the
antioxidant enzymes in an HIF-1α-independent manner. In conclusion,
paricalcitol improved the phenotype changes of pericyte to myofibroblast in TGF-β1-stimulated pericytes. In addition,
paricalcitol improved the expression of
fibrosis markers in
hypoxia-exposed pericytes both in an HIF-1α-dependent and independent manner.